BackTalis Biomedical Overview

Talis Biomedical Accounts Payable

Track Talis Biomedical's accounts payable ($3.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$3.79M
52.15% YoYΔ $1.30M vs prior year quarter

Peer average

Loading

Talis Biomedical Accounts Payable History

Loading

Talis Biomedical vs. peers: Accounts Payable Comparison

Loading

Talis Biomedical Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Talis Biomedical (TLIS) FAQ

As of the most recent data (June 2024), TLIS shows a accounts payable of $3.8M. That compares with $2.5M in the prior-year period — up 52.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TLIS's accounts payable is now $3.8M (was $2.5M) — a 52.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Talis Biomedical is outperforming or lagging.

Tracking TLIS's accounts payable over time shows whether Talis Biomedical is scaling, shrinking, or reshaping that part of the business. The current reading is $3.8M That compares with $2.5M in the prior-year period — up 52.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Talis Biomedical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $3.8M) with ownership activity and broader fundamentals.

Talis Biomedical's accounts payable is $3.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.